prednisolone has been researched along with Squamous Cell Carcinoma of Head and Neck in 1 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
Squamous Cell Carcinoma of Head and Neck: The most common type of head and neck carcinoma that originates from cells on the surface of the NASAL CAVITY; MOUTH; PARANASAL SINUSES, SALIVARY GLANDS, and LARYNX. Mutations in TNFRSF10B, PTEN, and ING1 genes are associated with this cancer.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, SB | 1 |
| Kim, KM | 1 |
| Park, MH | 1 |
| Kang, KP | 1 |
1 other study available for prednisolone and Squamous Cell Carcinoma of Head and Neck
| Article | Year |
|---|---|
Collapsing focal segmental glomerulosclerosis in a patient with oral cavity cancer: A case report.
Topics: Biopsy; Chemotherapy, Adjuvant; Dose-Response Relationship, Drug; Female; Glomerulosclerosis, Focal | 2021 |